Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam or propofol with or without esketamine for intraoperative hypotension in laparoscopic surgery
ChiCTR2300073619Phase 4Not yet recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam, propofol and esketamine in intraoperative hypotension (IOH) (4 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: Incidence of intraoperative hypotension. Planned start Jul 2023; status: not yet recruiting.
02
Drugs
remimazolampropofolesketamine
03
Conditions
intraoperative hypotension (IOH)
Beyond the preview
Go deeper on ChiCTR2300073619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073619.